arrow
A

Andrea Knežević

Memorial Sloan Kettering Cancer Center
H指数:35
被引数:4,556

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

24 A Phase 1b/2 Study of Abemaciclib Plus Cabozantinib in Immune Checkpoint Blockade-Pretreated Metastatic Clear Cell Renal Cell Carcinoma and Translocation-Associated Renal Cell Carcinoma (NCT06835972)

24 一项关于阿贝西利联合卡博替尼在免疫检查点阻断预处理后的转移性透明细胞肾细胞癌和转位相关肾细胞癌中的1b/2期研究(NCT06835972)

2026-09-020
OAAI
A Prospective Study of Safety and the Incremental Diagnostic Value of Transbronchial Cryobiopsy Incorporated into Robotic-Assisted Bronchoscopy in a Cancer Population

一项前瞻性研究,探讨在机器人辅助支气管镜检查中纳入经支气管冷冻活检的安全性及其增量的诊断价值,以癌症患者群体为研究对象。

Lung
IF3.9
2025-12-180
PRE
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone

单纯局部治疗后转移性透明细胞肾细胞癌的长期肿瘤学结果

2025-12-010
PRE
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

病理反应与接受延迟性肾切除术的转移性肾细胞癌患者的生存期相关

2025-11-260
PRE
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma

一项关于talazoparib和axitinib治疗晚期透明细胞肾细胞癌的1b/2期研究

2025-03-290
PRE
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)

卡博替尼联合纳武利尤单抗治疗非透明细胞肾细胞癌:一项II期试验的更新结果(卷86,页90,2024)

2025-01-010
PRE
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery

肾细胞癌脑转移灶经立体定向放射外科治疗后的临床结局与靶向基因组分析

2024-08-010
PRE